Since 1992 chronic renal failures have been detected in women that have absorbed pills containing chinese herbs extracts. The more fortunate of them underwent kidney transplant surgery, others survive thanks to hemodialysis, a third category either suffers from urinal cancer or either are deceased. Commercialized by Arkopharma (e.g. Health From The Sun) asiatitrat pills - which contained those extracts - were absorbed in the early 90's by 2,000 to 3,000 women in France and even more in Belgium where 1 million pills were sold. To date criminal proceedings against Max Rombi - Arkopharma's founder and ex-CEO - are ongoing since 1994. Max Rombi is pursued for homicides, injuries, frauds and misleading advertising. In October 2005 Max Rombi has been found guilty and sentenced to serve two years in jail and pay 20,000 euros penalty for "unintentional" homicides by Nice (France) correctional court. After fourteen years of procedures in a complete U-turn, on July the 5th of 2006, Max Rombi is acquitted of the charges of "unintentional" injuries by Toulouse (France) correctional court. Max Rombi has appealed both correctional courts sentences. Once more victims are insulted...

The figures shown below relate to known cases which means there are other women whom havng absorbed Arkopharma's asiatitrat pills and having lost their kidneys do not realize the cause of their renal failure. The purpose of this blog is to bring to public knowledge a problem that concerns us all and wherein an unscrupulous individual veterinary improvising himself as an expert in chinese medecine sold pills through the company he founded regardless of public health and safety standards...

Wednesday, August 16, 2006

Uneasiness

As we're leaving messages in forums we can see comments such as "That was in the early 90's...", "Those arkocapsules are not sold any longer...", "Arkopharma is a huge company internationnally respected...", "Mr Rombi is the one responsible, not Arkopharma...". Sentences that terribly show how much their authors don't feel concerned. After all while it doesn't happen to them...

The thing is some Arkopharma products lots are regularly and discretely removed from the market cautiously as not to make waves (see recent list from the French agency for sanitary safety). Before asiatitrat was withdrawn there were victims already. It's not because a product is withdrawn from the french market that it's withdrawn from the foreign ones. And when it's finally removed it's always after a non-negligeable laps of time. Arkopharma expanded not due to its "fame" but as part of a strategic economic international growth. Sure the firm makes 47% of its turnover out of France but are the consumers and potential consumers of its products well informed when products lots are withdrawn when they are and what for? Do they know some arkocapsules are responsible for serious health damages including death of women? Do they know herbs used in those arkocapsules do not have the properties claimed by Arkopharma? Do they know Max Rombi - then Arkopharma's CEO and founder and current chairman of the supervisory board - has been condemned for fraud and misleading advertisement for a product other than asiatitrat? At last would the authors of those comments trust a company which supporting its ex-CEO and founder and current chairman of its supervisory board doesn't seem to have retained its lesson by not acknowledging its mistakes - and therefore not assuming its responsabilities for the products involved and the firm has commercialized - and which unique defense policy consists in the systematical denial of facts in despite of overwhelming reports?

Once again we're inviting the authors of those comments to read our previous posts and articles, and we're still encouraging our readers to leave any comment they might have in our blog. We hope our readers we'll realize this is a problem that concerns all of us at last. In their constant fight for justice the victims will always be disadvantaged without such take of conscience and hence without the support of the public opinion in front of Max Rombi ex-CEO founder and current chairman of the supervisory board of Arkopharma, which realizes an annual turnover of approx. 230 millions euros, company that is still supporting him and which majority of shares is owned by the Rombi family.

0 Comments:

Post a Comment

<< Home